NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

PRPH

ProPhase Labs Inc

Jul 02 • 04:00PM ET

0.4037

Dollar change +0.0217
Percentage change 5.68	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: JNJ PFE MRNA BMY GILD ABBV LLY VRTX REGN VTRS

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.50	Insider Own	11.73%	Shs Outstand	41.54M	Perf Week	15.67%
Market Cap	16.77M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	36.67M	Perf Month	8.03%
Enterprise Value	30.69M	PEG	-	EPS next Q	-	Inst Own	12.02%	Short Float	0.43%	Perf Quarter	-0.07%
Income	-27.76M	P/S	1.32	EPS this Y	-	Inst Trans	103.17%	Short Ratio	0.06	Perf Half Y	-36.62%
Sales	12.75M	P/B	1.08	EPS next Y	-	ROA	-30.25%	Short Interest	0.16M	Perf YTD	-46.68%
Book/sh	0.38	P/C	186.35	EPS next 5Y	-	ROE	-58.71%	52W High	4.03 -89.97%	Perf Year	-90.34%
Cash/sh	0.00	P/FCF	-	EPS past 3/5Y	- -57.56%	ROIC	-116.62%	52W Low	0.22 85.27%	Perf 3Y	-96.89%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-55.92% -7.27%	Gross Margin	-32.38%	Volatility	7.76% 9.45%	Perf 5Y	-70.12%
Dividend TTM	-	EV/Sales	2.41	EPS Y/Y TTM	-141.87%	Oper. Margin	-277.69%	ATR (14)	0.04	Perf 10Y	-43.71%
Dividend Ex-Date	May 24, 2022	Quick Ratio	0.98	Sales Y/Y TTM	-79.66%	Profit Margin	-217.64%	RSI (14)	62.01	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.03	EPS Q/Q	72.02%	SMA20	12.99%	Beta	-0.48	Target Price	16.00
Payout	-	Debt/Eq	0.90	Sales Q/Q	-59.10%	SMA50	16.79%	Rel Volume	0.31	Prev Close	0.38
Employees	96	LT Debt/Eq	0.53	Earnings	May 20 BMO	SMA200	-51.77%	Avg Volume	2.68M	Price	0.40
IPO	Apr 22, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	27.78% -41.59%	Trades		Volume	831,398	Change	5.68%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-20-21	Initiated	H.C. Wainwright	Buy	$12
Oct-13-21	Downgrade	Dawson James	Buy → Neutral
Jan-20-21	Initiated	Dawson James	Buy	$25

Jun-26-25 07:30AM	ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule (GlobeNewswire)
Jun-18-25 11:19AM	Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going (PR Newswire)
Jun-17-25 07:30AM	ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart Test in Detecting Esophageal Cancer (GlobeNewswire) +5.23%
Jun-06-25 07:00AM	ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform (GlobeNewswire)
May-21-25 05:00PM	ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges (GuruFocus.com) -12.42% +6.97%
08:00AM	Loading…
May-20-25 08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 (GlobeNewswire)
May-15-25 06:00PM	Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +7.28%
May-14-25 08:15AM	ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +8.24%
May-13-25 08:00AM	ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 (GlobeNewswire)
May-07-25 06:45PM	Inotiv, Inc. (NOTV) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +5.73% +6.29%
May-05-25 08:20AM	BioCryst Pharmaceuticals (BCRX) Reports Break-Even Earnings for Q1 (Zacks) -10.92%
Apr-03-25 09:00AM	ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges (GuruFocus.com) -11.28%
Mar-31-25 09:08PM	ProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call Transcript (Seeking Alpha) -8.11%
08:00AM	ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024 (GlobeNewswire)
Mar-27-25 08:27AM	ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 (GlobeNewswire)
05:20PM	Loading…
Mar-26-25 05:20PM	Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Mar-18-25 03:30PM	Q1 Virtual Investor Summit: On-Demand Presentations Now Live (ACCESS Newswire)
Mar-07-25 08:00AM	ProPhase Labs to Present at the Investor Summit Virtual on March 11 (GlobeNewswire)
Mar-05-25 09:55AM	Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now (Zacks) +8.27%
Feb-26-25 08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire) -9.82%
Feb-25-25 08:00AM	ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs (GlobeNewswire) -8.63%
Feb-20-25 08:00AM	ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables (GlobeNewswire)
Feb-18-25 08:00AM	ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports (GlobeNewswire) +35.08%
Jan-22-25 08:00AM	ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm (GlobeNewswire) -16.08%
Dec-11-24 08:00AM	ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures (GlobeNewswire)
Nov-19-24 08:00AM	Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision (GlobeNewswire)
Nov-18-24 08:01PM	ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... (GuruFocus.com)
08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
Nov-13-24 09:15AM	ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024 (GlobeNewswire)
04:05PM	Loading…
Nov-12-24 04:05PM	ProPhase Labs Announces Closing of Public Offering of Common Stock (GlobeNewswire)
Nov-11-24 09:52AM	ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 (GlobeNewswire) -5.26%
Nov-07-24 11:37PM	ProPhase Labs Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -26.29% -45.45%
04:05PM	ProPhase Labs Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Nov-04-24 08:00AM	ProPhase Labs Launches DNA Complete : Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry (GlobeNewswire)
Oct-22-24 08:00AM	ProPhase Labs to Present at the 2024 ThinkEquity Conference (GlobeNewswire)
Oct-17-24 08:00AM	ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 (GlobeNewswire)
Sep-11-24 01:00PM	Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing (ACCESSWIRE)
Aug-27-24 08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
Aug-22-24 08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
Aug-19-24 11:10AM	ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event (GlobeNewswire) +17.60%
Aug-14-24 08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024 (GlobeNewswire)
Aug-13-24 08:00AM	ProPhase Labs Announces Collaboration with Forward Healthcare Consultants to Aid in the Commercialization of its Billion Dollar Potential BE-Smart Esophageal Cancer Test (GlobeNewswire) -6.79%
Aug-07-24 08:00AM	PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14 (GlobeNewswire) -5.49%
Jul-11-24 08:00AM	ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress (GlobeNewswire)
May-16-24 08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
May-10-24 04:19PM	ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 03:40PM	ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated (GlobeNewswire) -8.72%
08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. (GlobeNewswire)
May-02-24 10:01AM	ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
08:00AM	PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9 (GlobeNewswire)
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-25-24 08:00AM	ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 (GlobeNewswire)
Apr-23-24 09:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire) +5.31%
Apr-16-24 08:00AM	ProPhase Labs Unveils Project ZenQ-AI (GlobeNewswire) +19.42%
Apr-10-24 08:00AM	ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024 (GlobeNewswire)
Apr-01-24 09:00PM	ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.87%
Mar-18-24 09:20AM	ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:08AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
Mar-15-24 12:53PM	PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
08:00AM	ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives (GlobeNewswire)
Mar-08-24 08:00AM	PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024 (GlobeNewswire)
Feb-21-24 08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
Feb-20-24 08:00AM	ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART (GlobeNewswire)
Feb-14-24 08:00AM	ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir (GlobeNewswire)
Feb-08-24 08:00AM	Diamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI) (GlobeNewswire)
Jan-30-24 08:00AM	ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics (GlobeNewswire)
Jan-23-24 08:00AM	Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts (GlobeNewswire)
Jan-04-24 08:00AM	ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024 (GlobeNewswire)
Nov-10-23 01:50PM	ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript (Insider Monkey) -10.78%
Nov-09-23 09:25AM	ProPhase Labs Inc (PRPH) Reports Mixed Q3 Results Amid Strategic Transformations (GuruFocus.com) +7.82%
08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023 (GlobeNewswire)
Nov-02-23 08:00AM	ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time (GlobeNewswire)
Oct-17-23 08:00AM	ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output. (GlobeNewswire)
Oct-12-23 08:25AM	DSS Inc. Issues Letter to Shareholders (GlobeNewswire)
08:00AM	ProPhase Labs to Present at The ThinkEquity Conference (GlobeNewswire)
Aug-10-23 10:40AM	ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call. (GlobeNewswire) -9.89%
09:30AM	ProPhase Labs, Inc. (PRPH) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023 (GlobeNewswire)
Aug-03-23 08:00AM	ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound (GlobeNewswire)
Aug-02-23 08:00AM	ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time (GlobeNewswire)
Jun-29-23 08:00AM	Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea (GlobeNewswire)
Jun-22-23 08:30AM	ProPhase Labs Inc. Sets the Course for Expansion into the MENA Region with Cutting-Edge Genomic and Diagnostics Technologies (GlobeNewswire)
Jun-09-23 08:00AM	Diamond Equity Research to Host Global Select Emerging Growth Invitational Virtual Investor Conference on June 13th, 2023 (GlobeNewswire)
Jun-07-23 08:00AM	ProPhase Labs to Present at the Diamond Equity Research Emerging Growth Invitational on Tuesday, June 13, 2023 (GlobeNewswire)
Jun-01-23 08:30AM	ProPhase Labs Cancer Therapeutic, Linebacker-1, pre-clinical studies with Dana Farber/Harvard Cancer Institute demonstrate impressive utility and move into next phase of testing (GlobeNewswire)
May-11-23 09:35AM	ProPhase Labs, Inc. (PRPH) Beats Q1 Earnings and Revenue Estimates (Zacks)
08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2023 (GlobeNewswire)
May-08-23 08:30AM	ProPhase Labs hires Dr. Matthew Halpert to Drive Companys Key Therapeutic and Diagnostic Oncology Programs (GlobeNewswire)
May-04-23 08:30AM	ProPhase Labs to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 11, 2023 at 11:00 a.m. Eastern Time (GlobeNewswire) -9.64%
May-03-23 08:30AM	ProPhase Labs Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancers (GlobeNewswire) +8.43%
03:43AM	ProPhase Labs, Inc. (PRPH) Surges 8.5%: Is This an Indication of Further Gains? (Zacks)
May-01-23 08:00AM	Diamond Equity Research Initiates Coverage on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
01:54AM	Catalent (CTLT) Stock Jumps 6.8%: Will It Continue to Soar? (Zacks)
Apr-28-23 08:30AM	ProPhase Labs CEO Ted Karkus Named One of Inc Magazines 10 Most Innovative Healthcare Leaders to Watch in 2023 (GlobeNewswire)
Apr-27-23 06:36PM	7 Small-Cap Biotech Stocks with Massive Potential (InvestorPlace)
08:03AM	Could The Market Be Wrong About ProPhase Labs, Inc. (NASDAQ:PRPH) Given Its Attractive Financial Prospects? (Simply Wall St.)
08:00AM	COMSovereign Names Bill White, CFE as New Independent Director and Chair of Audit Committee (PR Newswire)
Apr-25-23 08:30AM	ProPhase Labs Announces Launch of Redesigned Corporate Website (GlobeNewswire)
Apr-24-23 09:00AM	Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV (ACCESSWIRE)

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRPH

ProPhase Labs Inc

Upgrade your FINVIZ experience